Pharmacological Interventions in Labor and Delivery.

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Maternal-Fetal Medicine

Background:

• Limited availability of pregnancy-specific drugs necessitates specialized pharmacological strategies for high-risk obstetric conditions.
• Established pharmacological approaches are crucial for managing preterm birth, labor induction/augmentation, and postpartum hemorrhage.

Purpose of the Study:

• To review existing and emerging evidence on pharmacological interventions in obstetric care.
• To assess the impact of these approaches on clinical practice.
• To discuss the limitations of current therapeutics and future directions.

Main Methods:

• Literature review of established and emerging evidence.
• Analysis of pharmacological mechanisms targeting myometrial physiology.
• Discussion of novel agents and improved formulations.

Main Results:

• Pharmacological approaches are foundational in managing common and problematic antenatal and intrapartum complications.
• Current therapeutics primarily target myometrial hormonal receptors, signaling pathways, or ion channels.
• Emerging drugs represent refinements of existing strategies, alongside novel plant-derived agents and advanced formulations.

Conclusions:

• Pharmacological interventions are essential for high-risk obstetric care, despite limitations in drug availability.
• Understanding myometrial physiology guides the development of both current and future obstetric drugs.
• Continued research into novel agents and formulations holds promise for advancing obstetric management.